ClinicalTrials.gov
ClinicalTrials.gov Menu

Predicting Response and Toxicity in Patients Receiving Lonafarnib for Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01232881
Recruitment Status : Terminated (funding terminated)
First Posted : November 2, 2010
Last Update Posted : April 28, 2011
Sponsor:
Collaborators:
United States Department of Defense
Indiana University School of Medicine
Emory University
Information provided by:
Hoosier Cancer Research Network

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : November 2010
  Actual Study Completion Date : November 2010